Key result
Oral shedding of HSV-1 was detectable in 87% of adults with recurrent herpes labialis for a mean of 4 days, occurring frequently in both clinical (50%) and subclinical (23%) stages.
Why the study?
What is the frequency, timing, and quantity of oral HSV-1 shedding during a recurrent herpes labialis episode in immunocompetent adults?
Observational (n=30)
What is the frequency, timing, and quantity of oral HSV-1 shedding during a recurrent herpes labialis episode in immunocompetent adults?
The majority of patients with recurrent herpes labialis shed viral DNA before and after the appearance of clinical lesions, highlighting the potential for transmission during subclinical stages.
Supports subclinical HSV-1 transmission counseling in recurrent herpes labialis; leaves open whether antivirals reduce asymptomatic shedding.
Background: Reactivation of herpes simplex virus‐1 (HSV‐1) can result in recurrent herpes labialis lesions (RHL) and in oral shedding of virus. This study utilized polymerase chain reaction (PCR) to document the frequency and quantity of such shedding. Methods: Thirty adults with greater than three RHL episodes per year were followed through one recurrence. They collected swabs for PCR every 12 h starting at prodrome and for 10 days thereafter. Shedding was analyzed with regard to frequency, timing and quantity. Results: HSV‐1 was detectable in 87% of participants for a mean of 4 days. Shedding occurred most frequently during the vesicle/ulcer stage (91% of subjects), but was common in both clinical and subclinical stages (50% vs. 23%, average log DNA copy number/ml 2 2.6 vs. 1.4). Conclusion: The majority of RHL patients shed viral DNA. Shedding occurred before and after the appearance of clinical lesions. Such findings may be useful in designing methods to reduce viral shedding and prevent transmission.
No takes yet. Share an insight, caveat, or question.
Stanley C. Gilbert (2006) conducted an observational in Recurrent herpes labialis (n=30). Oral shedding of HSV-1 was detectable in 87% of adults with recurrent herpes labialis for a mean of 4 days, occurring frequently in both clinical (50%) and subclinical (23%) stages.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: